SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001493152-24-031347
Filing Date
2024-08-12
Accepted
2024-08-12 17:10:21
Documents
3

Document Format Files

Seq Description Document Type Size
1 form424b3.htm 424B3 235448
2 logo_001.jpg GRAPHIC 13972
3 logo_002.jpg GRAPHIC 13972
  Complete submission text file 0001493152-24-031347.txt   275512
Mailing Address 855 N. WOLFE STREET SUITE 601 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 601 BALTIMORE MD 21205 856-848-8698
TNF Pharmaceuticals, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-280415 | Film No.: 241197878
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)